Data de publicação: 20/04/2021 - 16:01
A study by researchers of the Oxford University shows that the risk of cerebral venous thrombosis (CVT) in people with COVID-19 is considerably higher than in those who have been vaccinated with mRNA (messenger RNA) vaccines, such as those by Pfizer and Moderna. In addition to mRNA vaccines, the analysis also included the Oxford/AstraZeneca immunizer, produced in Brazil by the Oswaldo Cruz Foundation (Fiocruz).
The survey Cerebral venous...
Notícias
Data de publicação: 08/07/2016 - 14:28
Modelo da Fiocruz de Termo de Transferência de Material (TTM) para remessas para o exterior em português e inglês.
Fiocruz Model of Material Transfer Agreement (MTA) for shipments abroad in Portuguese and English.
Documento/Arquivo
Data de publicação: 18/03/2021 - 13:30
The United Kingdom ambassador in Brazil, Peter Wilson, visited the Oswaldo Cruz Foundation (Fiocruz) on March 5 for a meeting with the president of the institution, Nísia Trindade Lima, and to visit the Immunobiological Technology Institute (Bio-Manguinhos) plant that is producing the Covid-19 Fiocruz vaccine.
Photo: Pedro Paulo Gonçalves
“I greatly admire the work you have you been doing, and we are here to know...
Notícias
Data de publicação: 30/04/2021 - 17:22
A study by Fiocruz and WWF-Brasil shows that the wildfires in the Amazon were responsible for the increase in the percentages of hospitalizations due to respiratory problems in the last 10 years (2010-2020) in states with higher numbers of hot spots: Pará, Mato Grosso, Rondônia, Amazonas and Acre. These hospitalizations cost the public treasury almost 1 billion. The survey also points out that the association of the pandemic...
Notícias
Data de publicação: 19/04/2021 - 15:55
A “pandemic of inequalities”, which denies people access to water to wash their hands, is one of the factors that have worsened the dissemination of Sars-CoV-2 in Latin America and in the Caribbean. This is the assessment of the UN High Commissioner for Human Rights and former president of Chile, Michelle Bachelet. A physician herself, last Thursday (April 15) she opened the Advanced Seminaries on Global Health and Health Diplomacy...
Notícias
Data de publicação: 18/06/2021 - 09:55
The G7 summit wraps up an important cycle of top-level meetings to evaluate and propose directions for the global fight against the COVID-19 pandemic. Preceded by the G20 Summit on Global Health and the World Health Assembly, both held during the second half of May, the G7 Summit took place last week in Carbsi Bay, Cornwell, United Kingdom, the first to be held after the Trump era.
One of the priority topics was the pandemic. The world had...
Notícias
Data de publicação: 07/06/2021 - 13:01
The Independent Panel on Pandemic Preparedness1 released on 11 May adds to the mounting calls for a new Pandemic Treaty that would address gaps in the global governance of threats to global health security. The emerging debate has quickly turned to focus on questions of structure and forms — a United Nations treaty or a framework convention under the auspices of the WHO, and verification and enforcement mechanisms — as well as...
Notícias
Data de publicação: 18/06/2021 - 16:49
A study by Public Health England (PHE) showed that applying two doses of the AstraZeneca vaccine results in 92% effectiveness against hospitalization due to the Delta (B.1.617.2) variant of the Sars-CoV-2. The variant, formerly known as the Indian variant, has been spreading through the United Kingdom like wildfire and there have been confirmed cases in Brazil as well. The vaccine has also shown high effectiveness against the Alpha (B.1.1.7)...
Notícias
Data de publicação: 24/05/2021 - 17:32
Beatriz Grinsztejn, head of the INI’s Laboratory of Clinical Research on STDs and AIDS, was granted last Wednesday (March 19) the Ward Cates Spirit Award by the HIV Prevention Tests Network (HPTN). Anthony Fauci, director of the National Institute of Allergies and Infectious Diseases (NIAID) of the United States, attended the event.
The award was given by Myron Cohen, the main investigator of the network. More than one thousand...
Notícias
Data de publicação: 31/05/2021 - 10:16
This Wednesday (26/5), at a Deliberative Session at the Plenary, the Chamber of Deputies approved Bill 2077/2019 that establishes the title of Public Health National Heritage and awards it to Fiocruz. The title is granted to governmental and private non-profit institutions who provide relevant and remarkable services to public health and that have technical, scientific, educational, wellfare activities, activities of social participation,...
Notícias
Data de publicação: 09/06/2021 - 09:40
The Bulletin of the Fiocruz COVID-19 Observatory, released last Friday (June 4th), concluded there is a rising trend for Severe Acute Respiratory Syndrome (SARS) in 12 states, in addition to the Federal District, in epidemiological week 21, between May 23rd and 29th. All regions have worrying figures, mainly those in the South and in the Central-West Brazilian regions. About 96% of SARS cases are caused by the new coronavirus.
The relation...
Notícias
Data de publicação: 28/05/2021 - 11:43
In a paper published (5/25) on Nature Medicine, researchers of the Fiocruz Genomic Network and of partner institutions point to the cause of the increase in the number of COVID-19 cases in the state of Amazonas and of the successive replacements of lineages of Sars-CoV-2. The study shows that these factors have been boosted by a combination of reduced social distancing measures and the appearance of a new, more transmissible form of the virus,...
Notícias
Data de publicação: 19/05/2021 - 10:50
The dengue virus is one of the greatest threats to public health in globe tropical regions, and especially in Brazil, where annual epidemics lead to thousands of Brazilians sickness. In the year 2019 alone, there were 2.1 million cases. However, something very intriguing happened in the years 2017-2018, right after the zika, dengue and chikungunya virus’s triple epidemic in 2016. Dengue fever case numbers were reported well below average...
Notícias
Data de publicação: 25/01/2021 - 12:53
In a partnership with the Amazonas Foundation for Health Surveillance (FVS-AM), researchers of the Leônidas and Maria Deane Institute (ILMD/Fiocruz Amazon) have confirmed the second case of reinfection by the Sars-CoV-2 in Brazil. The reinfection occurred in manaus, capital of the state of Amazonas, by the new variant identified in the state, designateed B.1.1.28.1 or P.1. The case was confirmed by virologist and researcher Felipe Naveca....
Notícias
Data de publicação: 08/03/2021 - 18:31
In a technical release issued last Thursday (March 3) by the Fiocruz Covid-19 Observatory, researchers warn of the geographical dispersion, in the territory, of “worrying variants” and of their high prevalence in the three Brazilian regions under study (South, South-East and North-East).
The new RT-PCR protocol, developed by Fiocruz Amazônia, was used by Fiocruz diagnostic support units and testing stations...
Notícias
Data de publicação: 10/03/2021 - 12:53
Many affluent countries, with the necessary technological capabilities and expertise, entered into the production of Covid-19 vaccines or sought the biopharmaceutical companies to block them for themselves through anticipated buying. It is estimated that as early December 2020, 3.8 billion vaccine doses had been guaranteed to these countries by several producers. If one compares that figure with the 3.2 billion doses, that include the 700...
Notícias
Data de publicação: 10/03/2021 - 18:21
Fiocruz president, Nísia Trindade Lima, participated in a World Health Organization (WHO) discussion on how investing in research on Covid-19 treatments can increase cooperation at national and international levels, on March 3. The discussion table, named Towards a Shared Research Agenda, included in the debate on how to identify knowledge gaps and research priorities for COVID-19 treatments, to incentivize cooperation and...
Notícias
Data de publicação: 12/03/2021 - 11:49
In an extraordinary edition of its Bulletin, the Covid-19 Fiocruz Observatory publishes an updated of the historical series on the occupation of COVID-19 ICU beds for adults in the Brazilian Health System (SUS, in the Portuguese acronym), with data obtained on Monday (8/3). The analysis presents rates verified since July 17th, 2020, and aims to alert to the critical scenario of the country. Check out the full document (in Portuguese)....
Notícias
Data de publicação: 15/03/2021 - 11:54
The Brazilian Health Regulatory Agency (Anvisa) granted the definitive registration of the COVID-19 Fiocruz vaccine on March 12. Thus, Fiocruz becomes the first holder of a registration of a COVID -19 vaccine produced in the country and adds to its product portfolio the eleventh vaccine to be supplied to the National Immunization Program (PNI). With the registration, the expectation is that Anvisa will authorize the release of the...
Notícias
Data de publicação: 15/03/2021 - 14:20
On March 11, one year since the World Health Organization (WHO) declared that the COVID-19 epidemic represented a global pandemic, the new Bulletin of the COVID-19 Observatory Fiocruz highlights that Brazil is among the countries with the worst indicators. The country totals 11,122,429 cases and 268,370 deaths, which corresponds to 9.5% and 10.3% of the global total, respectively, even though the Brazilian population is less than 3% of the world...
Notícias
Data de publicação: 17/03/2021 - 09:46
Faced with the current pandemic scenario, Fiocruz released this Tuesday (March 16), another edition of the Fiocruz COVID-19 Observatory Extraordinary Bulletin. The analysis draws attention to the indicators that point to an extremely critical situation across the country. In the view of the researchers who carry it out, this is the biggest health system collapse in the history of Brazil.
The Bulletin shows that, at the moment, of the...
Notícias
Data de publicação: 18/03/2021 - 10:39
Six years after the National Health Emergency declared by the Brazilian Ministry of Health, Zika is still a public health issue that mobilizes many actors in society. Fiocruz is launching the virtual exhibition Zika: lives affecting lives, produced by the Zika Social Sciences Network and the Oswaldo Cruz House (COC/Fiocruz), through the Museum of Life. The exhibition is the result of collaborative scientific research, produced with intense...
Notícias
Data de publicação: 01/04/2021 - 10:02
The Bulletin of the Fiocruz Covid-19 Observatory, released on March 26, shows that the country is facing the collapse of the health system. At the same time, the pandemic is now taking up new shapes, affecting younger age groups: 30 to 39 years old, 40 to 49, and 50 to 59. In such a scenario, researchers defend the adoption of measures in two interconnected groups.
The first group includes urgent measures that involve the containment of the...
Notícias
Data de publicação: 06/04/2021 - 09:24
With the start of Oxford/AstraZeneca-Fiocruz production vaccine on national territory, and the batches delivery to the Ministry of Health, this stage is beginning to give its first results to Brazilian society. Still this year, the country will have a vaccine produced entirely in Brazil and already in this first semester the manufacture of the first batches of the active pharmaceutical ingredient (API) will start, which should be available to...
Notícias
Data de publicação: 09/04/2021 - 09:08
A paper to be published in May in the U.S. Centers for Disease Control and Prevention's (CDC/US) journal Emerging Infectious Diseases (EID) shows that a first exposure to COVID-19 in mild or asymptomatic cases may not produce an immune response, and that a person can reinfect himself or herself with the same variant. The second infection can cause stronger symptoms than the first, the study indicates.
(Photo:Isabela Carrari -...
Notícias
O conteúdo deste portal pode ser utilizado para todos os fins não comerciais, respeitados e reservados os direitos morais dos autores.
